atrial myxoma
Jump to navigation
Jump to search
Introduction
Most common primary cardiac tumor.
Etiology
- sporadic
- associated with NAME or LAMB syndrome
Epidemiology
- sporadic form
- 39-82 years; mean age: 56 years
- female/male ratio 2.7/1
- associated with NAME syndrome or LAMB syndrome
- 10-56 years; mean age: 25 years
- female/male ratio 1.8/1
Pathology
- location:
- left atrium 75%
- right atrium 18%
- most arise from atrial septum (fossa ovalis)
- most myxomas have a short stalk, are gelatinous & friable, & tend to embolize
- left atrial tumors prolapse into the mitral valve & cause mitral stenosis
- occasionally calcify
- systemic emboli occur in 30-60% of patients with left-sided myxoma, frequently to brain & lower extremities
- sporadic form: 99% have single myxoma
- associated with NAME syndrome or LAMB syndrome
- 50% have multiple myxomas
- 57% with non-cardiac tumors
- 30% with associated endocrine tumor
- 13% with ventricular myxoma
Genetics
- associated with NAME syndrome or LAMB syndrome
- associated with defects in PRKAR1A gene (autosomal recessive)
Clinical manifestations
- obstruction to blood flow
- embolization
- systemic effects
- fatigue/malaise
- fever
- progressive dyspnea
- orthopnea
- weight loss
- arthralgia
- clubbing
- symptoms occur with changes in body position
- an early diastolic sound or tumor plop may be heard
- soft-mid diastolic murmur best heard at the cardiac apex
- may change with changes in body position
- autosomal dominant form (NAME syndrome or LAMB syndrome)
- 68% with associated freckles
- cardiac arrhythmias are uncommon[5]
Laboratory
- histologic examination of embolized material
- with systemic manifestations
Radiology
- calcified myxomas may be visible on chest X-ray
- echocardiogram
Complications
Differential diagnosis
- diastolic murmur similar to mitral stenosis
- mitral valve endocarditis associated with mitral regurgitation
- marantic endocarditis
- signs & symptoms of systemic embolization
- rarely murmurs
Management
- surgery
- left atrial myxoma should be removed even if patient is asymptomatic to avoid systemic embolism, embolic stroke[2]
- myxomas may be recurrent, thus periodic long-term follow-up is indicated[2]
More general terms
Additional terms
References
- ↑ Mayo Internal Medicine Board Review, 1998-99, Prakash UBS (ed) Lippincott-Raven, Philadelphia, 1998, pg 56
- ↑ 2.0 2.1 2.2 2.3 Medical Knowledge Self Assessment Program (MKSAP) 11, 14, 15, 16, 17, 18, 19. American College of Physicians, Philadelphia 1998, 2006, 2009, 2012, 2015, 2018, 2022.
- ↑ Harrison's Principles of Internal Medicine, 13th ed. Isselbacher et al (eds), McGraw-Hill Inc. NY, 1994, pg 1102
- ↑ Elbardissi AW, Dearani JA, Daly RC et al Embolic potential of cardiac tumors and outcome after resection: a case-control study. Stroke. 2009 Jan;40(1):156-62 PMID: https://www.ncbi.nlm.nih.gov/pubmed/18948602
- ↑ 5.0 5.1 Ali YS Fast Five Quiz: Heart Palpitations. Medscape. October 10, 2022 https://reference.medscape.com/viewarticle/981860